CASEY RENNO: Open Payments
NPI 1144866013 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 21 payments from 14 companies in 2025. Trend: 2023 $602 · 2024 $185 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Lilly USA, LLC | 3 | $48 |
| Genmab U.S., Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| PFIZER INC. | 1 | $22 |
| BeOne Medicines USA, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: REXULTI, Epkinly, FARXIGA, UBRELVY, VENCLEXTA, MOUNJARO, Fabhalta, NURTEC ODT.
Industry payments across MI — which companies pay providers there.
